162 related articles for article (PubMed ID: 19863558)
1. Differential IFN-alpha/beta production suppressing capacities of the leader proteins of mengovirus and foot-and-mouth disease virus.
Hato SV; Sorgeloos F; Ricour C; Zoll J; Melchers WJ; Michiels T; van Kuppeveld FJ
Cell Microbiol; 2010 Mar; 12(3):310-7. PubMed ID: 19863558
[TBL] [Abstract][Full Text] [Related]
2. The mengovirus leader protein blocks interferon-alpha/beta gene transcription and inhibits activation of interferon regulatory factor 3.
Hato SV; Ricour C; Schulte BM; Lanke KH; de Bruijni M; Zoll J; Melchers WJ; Michiels T; van Kuppeveld FJ
Cell Microbiol; 2007 Dec; 9(12):2921-30. PubMed ID: 17991048
[TBL] [Abstract][Full Text] [Related]
3. Evading the host immune response: how foot-and-mouth disease virus has become an effective pathogen.
Grubman MJ; Moraes MP; Diaz-San Segundo F; Pena L; de los Santos T
FEMS Immunol Med Microbiol; 2008 Jun; 53(1):8-17. PubMed ID: 18400012
[TBL] [Abstract][Full Text] [Related]
4. Foot-and-mouth disease virus leader proteinase inhibits dsRNA-induced type I interferon transcription by decreasing interferon regulatory factor 3/7 in protein levels.
Wang D; Fang L; Luo R; Ye R; Fang Y; Xie L; Chen H; Xiao S
Biochem Biophys Res Commun; 2010 Aug; 399(1):72-8. PubMed ID: 20638368
[TBL] [Abstract][Full Text] [Related]
5. Foot-and-Mouth Disease Virus Leader Protease Cleaves G3BP1 and G3BP2 and Inhibits Stress Granule Formation.
Visser LJ; Medina GN; Rabouw HH; de Groot RJ; Langereis MA; de Los Santos T; van Kuppeveld FJM
J Virol; 2019 Jan; 93(2):. PubMed ID: 30404792
[TBL] [Abstract][Full Text] [Related]
6. Alpha interferon is a powerful adjuvant for a recombinant protein vaccine against foot-and-mouth disease virus in swine, and an effective stimulus of in vivo immune response.
Cheng G; Zhao X; Yan W; Wang W; Zuo X; Huang K; Liu Y; Chen J; Wang J; Cong W; Liu M; Gao H; Chen J; Lu Y; Zheng Z
Vaccine; 2007 Jul; 25(28):5199-208. PubMed ID: 17555848
[TBL] [Abstract][Full Text] [Related]
7. Differential gene expression in bovine cells infected with wild type and leaderless foot-and-mouth disease virus.
Zhu J; Weiss M; Grubman MJ; de los Santos T
Virology; 2010 Aug; 404(1):32-40. PubMed ID: 20494391
[TBL] [Abstract][Full Text] [Related]
8. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.
Liu WJ; Wang XJ; Clark DC; Lobigs M; Hall RA; Khromykh AA
J Virol; 2006 Mar; 80(5):2396-404. PubMed ID: 16474146
[TBL] [Abstract][Full Text] [Related]
9. Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection.
de Los Santos T; Diaz-San Segundo F; Grubman MJ
J Virol; 2007 Dec; 81(23):12803-15. PubMed ID: 17881445
[TBL] [Abstract][Full Text] [Related]
10. Constitutive expression of alpha interferon by skin dendritic cells confers resistance to infection by foot-and-mouth disease virus.
Bautista EM; Ferman GS; Gregg D; Brum MC; Grubman MJ; Golde WT
J Virol; 2005 Apr; 79(8):4838-47. PubMed ID: 15795269
[TBL] [Abstract][Full Text] [Related]
11. Foot-and-mouth disease virus (FMDV) leader proteinase negatively regulates the porcine interferon-λ1 pathway.
Wang D; Fang L; Liu L; Zhong H; Chen Q; Luo R; Liu X; Zhang Z; Chen H; Xiao S
Mol Immunol; 2011 Oct; 49(1-2):407-12. PubMed ID: 21975014
[TBL] [Abstract][Full Text] [Related]
12. Foot-and-Mouth Disease Virus Antagonizes NOD2-Mediated Antiviral Effects by Inhibiting NOD2 Protein Expression.
Liu H; Zhu Z; Xue Q; Yang F; Cao W; Zhang K; Liu X; Zheng H
J Virol; 2019 Jun; 93(11):. PubMed ID: 30894473
[TBL] [Abstract][Full Text] [Related]
13. Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons.
Moraes MP; de Los Santos T; Koster M; Turecek T; Wang H; Andreyev VG; Grubman MJ
J Virol; 2007 Jul; 81(13):7124-35. PubMed ID: 17459931
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility to viral infection is enhanced by stable expression of 3A or 3AB proteins from foot-and-mouth disease virus.
Rosas MF; Vieira YA; Postigo R; Martín-Acebes MA; Armas-Portela R; Martínez-Salas E; Sobrino F
Virology; 2008 Oct; 380(1):34-45. PubMed ID: 18694581
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo.
Chen W; Liu M; Jiao Y; Yan W; Wei X; Chen J; Fei L; Liu Y; Zuo X; Yang F; Lu Y; Zheng Z
J Virol; 2006 Apr; 80(7):3559-66. PubMed ID: 16537624
[TBL] [Abstract][Full Text] [Related]
16. Expression of exogenous IFN-alpha by bypassing the translation block protects cells against FMDV infection.
Xiong Y; Lin M; Yuan B; Yuan T; Zheng C
Antiviral Res; 2009 Oct; 84(1):60-6. PubMed ID: 19607862
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional roles of leader protein of foot-and-mouth disease viruses in suppressing host antiviral responses.
Liu Y; Zhu Z; Zhang M; Zheng H
Vet Res; 2015 Oct; 46():127. PubMed ID: 26511922
[TBL] [Abstract][Full Text] [Related]
18. Development of a hamster kidney cell line expressing stably T7 RNA polymerase using retroviral gene transfer technology for efficient rescue of infectious foot-and-mouth disease virus.
Zheng H; Tian H; Jin Y; Wu J; Shang Y; Yin S; Liu X; Xie Q
J Virol Methods; 2009 Mar; 156(1-2):129-37. PubMed ID: 19095010
[TBL] [Abstract][Full Text] [Related]
19. Foot-and-Mouth Disease Virus Viroporin 2B Antagonizes RIG-I-Mediated Antiviral Effects by Inhibition of Its Protein Expression.
Zhu Z; Wang G; Yang F; Cao W; Mao R; Du X; Zhang X; Li C; Li D; Zhang K; Shu H; Liu X; Zheng H
J Virol; 2016 Dec; 90(24):11106-11121. PubMed ID: 27707918
[TBL] [Abstract][Full Text] [Related]
20. A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5'UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice.
Yang B; Lan X; Li X; Yin X; Li B; Han X; Li Y; Zhang Z; Liu J
Vaccine; 2008 Oct; 26(43):5477-83. PubMed ID: 18694793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
